Wells Fargo’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-21,110
| Closed | -$401K | – | 6487 |
|
2019
Q1 | $401K | Sell |
21,110
-1,159
| -5% | -$22K | ﹤0.01% | 4401 |
|
2018
Q4 | $300K | Buy |
22,269
+19,069
| +596% | +$257K | ﹤0.01% | 4515 |
|
2018
Q3 | $36K | Buy |
+3,200
| New | +$36K | ﹤0.01% | 5384 |
|
2017
Q1 | – | Sell |
-16,024
| Closed | -$78K | – | 6223 |
|
2016
Q4 | $78K | Hold |
16,024
| – | – | ﹤0.01% | 5013 |
|
2016
Q3 | $79K | Hold |
16,024
| – | – | ﹤0.01% | 4834 |
|
2016
Q2 | $82K | Sell |
16,024
-1,285
| -7% | -$6.58K | ﹤0.01% | 4759 |
|
2016
Q1 | $99K | Buy |
17,309
+419
| +2% | +$2.4K | ﹤0.01% | 4672 |
|
2015
Q4 | $175K | Buy |
16,890
+414
| +3% | +$4.29K | ﹤0.01% | 4383 |
|
2015
Q3 | $304K | Buy |
16,476
+197
| +1% | +$3.64K | ﹤0.01% | 4102 |
|
2015
Q2 | $318K | Buy |
16,279
+14,466
| +798% | +$283K | ﹤0.01% | 4223 |
|
2015
Q1 | $32K | Buy |
1,813
+783
| +76% | +$13.8K | ﹤0.01% | 5010 |
|
2014
Q4 | $16K | Buy |
1,030
+8
| +0.8% | +$124 | ﹤0.01% | 5245 |
|
2014
Q3 | $13K | Sell |
1,022
-477
| -32% | -$6.07K | ﹤0.01% | 5327 |
|
2014
Q2 | $23K | Buy |
1,499
+499
| +50% | +$7.66K | ﹤0.01% | 5183 |
|
2014
Q1 | $13K | Sell |
1,000
-8,189
| -89% | -$106K | ﹤0.01% | 5192 |
|
2013
Q4 | $148K | Buy |
9,189
+8,689
| +1,738% | +$140K | ﹤0.01% | 4313 |
|
2013
Q3 | $8K | Sell |
500
-700
| -58% | -$11.2K | ﹤0.01% | 5080 |
|
2013
Q2 | $12K | Buy |
+1,200
| New | +$12K | ﹤0.01% | 4921 |
|